Crescita Therapeutics Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was CAD 4.73 million compared to CAD 6.03 million a year ago. Net loss was CAD 0.15 million compared to net income of CAD 1.18 million a year ago.

Basic loss per share from continuing operations was CAD 0.01 compared to basic earnings per share from continuing operations of CAD 0.06 a year ago. Diluted loss per share from continuing operations was CAD 0.01 compared to diluted earnings per share from continuing operations of CAD 0.06 a year ago.